title: Immunosuppressive requirements for small bowel/liver transplantation.
authors.affiliation: Department of Surgery, University Hospital, London, Ontario, Canada.
authors.forename: V
authors.initials: V
authors.lastname: McAlister
authors.forename: D
authors.initials: D
authors.lastname: Grant
authors.forename: W
authors.initials: W
authors.lastname: Wall
authors.forename: A
authors.initials: A
authors.lastname: Roy
authors.forename: C
authors.initials: C
authors.lastname: Ghent
authors.forename: R
authors.initials: R
authors.lastname: Zhong
authors.forename: J
authors.initials: J
authors.lastname: Duff
mesh_terms: D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D003141:Communicable Diseases / Q000209:etiology; D016572:Cyclosporine / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D004386:Duodenum / Q000637:transplantation; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D007421:Intestine, Small / Q000637:transplantation*; D016031:Liver Transplantation / Q000276:immunology*; D008775:Methylprednisolone / Q000627:therapeutic use*; D016853:Muromonab-CD3 / Q000627:therapeutic use*; D016035:Pancreas Transplantation / Q000276:immunology; D011183:Postoperative Complications; D011241:Prednisone / Q000627:therapeutic use; D013270:Stomach / Q000637:transplantation; D014184:Transplantation, Homologous / Q000276:immunology*
chemical_list: D000961:Antilymphocyte Serum; D016853:Muromonab-CD3; D016572:Cyclosporine; D011241:Prednisone; D008775:Methylprednisolone